Alector, Inc. (ALEC)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$1.95+$0.0300 (+1.56%) on the dayAs of the close; data may be delayed.
ALEC price, last 12 months
Key stats
- Previous close
- $1.92
- Open
- $1.92
- Day range
- $1.90 – $2.05
- 52-week range
- $1.09 – $3.40
- Volume
- 1M
- Avg volume (20 days)
- 1.5M
- Market cap
- $217.7M
Performance
1W+2.1%
1M−20.7%
3M+4.8%
6M−8.0%
YTD+25.0%
1Y−38.3%
vs S&P 500, 1Y−55.1 pts
Technicals and fundamentals
About Alector, Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $217.7M